MeSH tree: C04.557.465.625.600.380
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
6
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults. In preclinical ...
May 13, 2026
0
9
Stem cells found in the lining of the mouth could help make the most aggressive form of brain cancer easier to treat, according to new research from the University of Reading. The stem cells release a mixture of proteins ...
May 13, 2026
0
4
Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
May 13, 2026
0
4
A team at Huntsman Cancer Institute at the University of Utah (the U) has uncovered a previously unrecognized molecular mechanism by which cells send signals to one another—an insight that could help researchers better understand ...
May 12, 2026
0
7
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appear to increase recurrence-free ...
May 12, 2026
0
17
All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. For a type of brain cancer called glioblastoma, ...
May 6, 2026
0
5
In a new study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men. The research team found that the loss of androgen ...
May 6, 2026
0
28
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
May 4, 2026
0
14
Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this type of cancer is often resistant to available treatments is that it is characterized by a highly diverse ...
